Latest Breaking News On - Intelgenx corp - Page 13 : comparemela.com

Global Drug Delivery Systems (DDS) Markets 2021-2027 - Increasing R&D Expenditures of Innovator Companies and the Trend of Patent Portfolio Expansion

Global Drug Delivery Systems (DDS) Markets 2021-2027 - Increasing R&D Expenditures of Innovator Companies and the Trend of Patent Portfolio Expansion
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Celares gmbErytech pharmaFordoz pharmaNovaliq gmbVigeneron gmbMidatech pharmaOz biosciencesLaura woodHoldings incCorium incOrbis biosciences incEvonik industries germanyIco therapeutics incArecor ltdHalozyme therapeutics incAcorporation inc

IntelGenx Technologies : Announces Subscription for Notes

IntelGenx Technologies : Announces Subscription for Notes
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSaint laurentStephen kilmerAndre godinIntelgenx corpCompany montelukastCompany theIntelgenx technologies corpVenture exchangeRegulation services providerGlobenewswire incGenx technologiesUnited states securities actLooking informationForward looking informationஒன்றுபட்டது மாநிலங்களில்

Oral Thin Film Drugs Market 2021 Development Plans of Top Companies – Sumitomo Dainippon Pharma Co , Ltd , Pfizer, Inc , Novartis AG , ZIM Laboratories Limited – KSU

The Oral Thin Film Drugs Market is expected to grow at a CAGR of 8.89% and is poised to reach US$XX Billion by 2027 as compared to US$XX Billion in 20

United statesUnited kingdomSunil kumarAllergan plcPfizer incWolters kluwerIntelgenx corpIndivior plcSumitomo dainippon pharma co ltdOral thin film drugs marketDecisive markets insightsSample copyOral thin film drugsMiddle eastNorth americaLatin america

Psyched: MindMed To Begin Mescaline Trials and Deepak Chopra Partnership, Seelos And Cybin Advance Clinical Research

MindMed’s News Spree: Mescaline Trials, Chopra Foundation Partnership and LSD Research MindMed (NASDAQ:MNMD) (NEO: MMED) released a series of new announcements following the company’s Q1 earnings report. The company reported Thursday that it had obtained authorization from one of the local Swiss ethics committees to conduct its first clinical trial on mescaline. The research is scheduled to begin in May at the University Hospital Basel Liechti Lab in Basel, Switzerland. The study will examine the effects of various doses of mescaline and “the role of the serotonin 5-HT2A receptor in a mescaline-induced altered state of consciousness.”

University of the west indiesSaint andrewRaj mehraDeepak chopraMatthias liechtiJamaica ministry of healthCybin incUniversity hospital basel liechti lab inIntelgenx corpSeelos therapeutics incUniversity of baselPharmather holdings ltdBc ltdChopra foundation partnershipChopra foundationNews spree

Cybin Moves Forward With Clinical Trial On Psilocybin Oral Film

Cybin Moves Forward With Clinical Trial On Psilocybin Oral Film Cybin Inc. (NEO: CYBN) (OTCQB:CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, announced on Tuesday it has received initial clearance to begin a Phase IIa clinical trial on psilocybin for patients suffering from major depressive disorders (MDD). The head-to-head study will test Cybin’s proprietary sublingual psilocybin formulation against a 25mg psilocybin capsule on 40 patients. The trial has been approved by a review board at the University of the West Indies in Jamaica, where the research will be undertaken. The company still awaits final confirmation by Jamaica’s Ministry of Health to begin testing the product on human subjects.

University of the west indiesSaint andrewDoug drysdaleJamaica ministry of healthCybin incIntelgenx corpInternational conference on harmonizationWest indiesInternational conferenceHarmonization good clinical practiceபல்கலைக்கழகம் ஆஃப் தி மேற்கு இண்டீஸ்துறவி ஆண்ட்ரூடக் ட்ரைஸ்டேல்ஜமைக்கா அமைச்சகம் ஆஃப் ஆரோக்கியம்மேற்கு இண்டீஸ்சர்வதேச மாநாடு